NCT03521778

Brief Summary

Relatively new method of diagnosing and treating dysfunction of the musculoskeletal system is Fascial Distortion Model. It is manual therapy developed by emergency physician and an osteopath Stephen P. Typaldos. Disfunction are diagnosed based on verbal and physical descriptions, palpations, anamnesis. As a result of examination, It can be found one or more of six different distortions. The aim of the study is to examine the effectiveness of FDM manual therapy in comparison to manual therapy using the Mulligan Concept method and traditional physiotherapy in patients with shoulder dysfunction who have undergone previous rehabilitation and who have not achieved satisfactory results. Patients will receive five treatments with one day brake between each treatment. The patient's condition will be evaluated before the first treatment, two weeks after the last treatment, and also after three months. As a outcome of the occurring phenomenon, structural changes are planned at the level of the fascial system in the studied region. The obtained results may influence the current views on diseases of the musculoskeletal system, as well as on the method of diagnosing and treating shoulder joint dysfunction.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2018

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2018

Completed
26 days until next milestone

First Posted

Study publicly available on registry

May 11, 2018

Completed
14 days until next milestone

Study Start

First participant enrolled

May 25, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2019

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

May 11, 2018

Status Verified

April 1, 2018

Enrollment Period

1.3 years

First QC Date

April 15, 2018

Last Update Submit

April 28, 2018

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change from baseline DASH Outcome Measure at 3 months

    The Disabilities of the Arm, Shoulder and Hand (DASH) Outcome Measure is a 30-item, self-report questionnaire designed to measure physical function and symptoms in patients with any or several musculoskeletal disorders of the upper limb. It helps describe the disability experienced by people with upper-limb disorders and also to monitor changes in symptoms and function over time .The DASH is scored in 30 items from 1 to 5. Higher score means greater level of disability.

    1'st day, 2 weeks after treatment, 3 months after treatment

  • Change from baseline Constant-Murley Shoulder Outcome Score at 3 months

    The Constant-Murley score (CMS) is a 100-points scale composed of a number of individual parameters. These parameters define the level of pain and the ability to carry out the normal daily activities of the patient.\[1\] The Constant-Murley score was introduced to determine the functionality after the treatment of a shoulder injury. The test is divided into four subscales: pain (15 points), activities of daily living (20 points), strength (25 points) and range of motion: forward elevation, external rotation, abduction and internal rotation of the shoulder (40 points). The higher score, the higher the quality of the function.

    1'st day, 3 months after treatment

  • Change from baseline Quality Of Life Questionnaire SF- 36v2 at 3 months

    The SF-36 is a 36 item questionnaire that measures eight multi-item dimensions of health: physical functioning (10 items) social functioning (2 items) role limitations due to physical problems (4 items), role limitations due to emotional problems (3 items), mental health (5 items), energy/vitality (4 items), pain (2 items), and general health perception (5 items).

    1'st day, 3 months after treatment

  • Change from baseline Visual Analogue Scale at 3 months

    Visual analogue scales (score 0-10) are psychometric measuring instruments designed to document the characteristics of disease-related symptom severity in individual patients and use this to achieve a rapid classification of symptom severity and disease control. The higher score, indicate greater level of pain.

    1'st day, 3 months after treatment

Study Arms (3)

Fascial Distortion Model group

EXPERIMENTAL

Patients will receive manual treatment complies with Fascial Distortion Model method.

Other: Fascial Distortion Model

Mulligan Concept group

EXPERIMENTAL

Patients will receive manual treatment complies with Mulligan Concept method.

Other: Mulligan Concept

Traditional physiotherapy group

EXPERIMENTAL

Patients will receive traditional physiotherapy.

Other: Traditional physiotherapy

Interventions

Patients will receive manual treatment according to FDM procedures: 1. Triggerbands - therapist put a pressure by the thumb along the presented pathway. 2. Continuum Distortions - therapist put a pressure by the thumb at the exact place of feeling of pain. 3. Folding Distortions - therapist conduct traction or compression of the affected joint. 4. Herniated Triggerpoint - therapist put a pressure by the thumb at the place where HTP occurs. 5. Cylinder Distortions - therapist compress and stretch by the hands affected area. 6. Tectonic Fixation - Therapist compress and stretch affected area by the hands or tools like vacuum bubble.

Also known as: Manual treatment- Fascial Distortion Model
Fascial Distortion Model group

Patients will receive manual treatment according to Mulligan Concept procedures: MWM- Mobilization With Movement- application can be defined as the application of a sustained passive force/glide. NAG - Natural Apophyseal Glide - application can be defined as the oscillatory mobilization techniques from the middle to the end of the range of motion. SNAG- Sustained Natural Apophyseal Glide- They are weight bearing techniques: all procedures are done with the patient sitting or in standing. They are mobilisations with active movement followed by passive over pressure.

Also known as: Manual treatment- Mulligan Concept
Mulligan Concept group

Patients will receive traditional physiotherapy: Exercises, laser treatment, magnetic field therapy, ultrasound treatment, light treatment

Traditional physiotherapy group

Eligibility Criteria

Age40 Years - 86 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of dysfunction in the shoulder joint based on an orthopedic and/or physiotherapeutic examination confirmed by X-ray and ultrasound imaging,
  • patients undergoing prior rehabilitation / pharmacotherapy / surgical intervention without satisfactory results,
  • limitation of mobility and / or pain in the shoulder complex,

You may not qualify if:

  • coexistence of neoplastic diseases,
  • symptoms from the cervical spine
  • pregnancy,
  • aneurysms,
  • osteitis,
  • arthritis
  • deep veins thrombosis of upper limbs,
  • resignation from the study / therapy,
  • skin damage, hematomas.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (19)

  • Tesarz J, Hoheisel U, Wiedenhofer B, Mense S. Sensory innervation of the thoracolumbar fascia in rats and humans. Neuroscience. 2011 Oct 27;194:302-8. doi: 10.1016/j.neuroscience.2011.07.066. Epub 2011 Aug 2.

    PMID: 21839150BACKGROUND
  • Liljencrantz J, Olausson H. Tactile C fibers and their contributions to pleasant sensations and to tactile allodynia. Front Behav Neurosci. 2014 Mar 6;8:37. doi: 10.3389/fnbeh.2014.00037. eCollection 2014.

    PMID: 24639633BACKGROUND
  • Olausson H, Wessberg J, Morrison I, McGlone F, Vallbo A. The neurophysiology of unmyelinated tactile afferents. Neurosci Biobehav Rev. 2010 Feb;34(2):185-91. doi: 10.1016/j.neubiorev.2008.09.011. Epub 2008 Oct 8.

    PMID: 18952123BACKGROUND
  • Stecco C, Macchi V, Porzionato A, Duparc F, De Caro R. The fascia: the forgotten structure. Ital J Anat Embryol. 2011;116(3):127-38.

    PMID: 22852442BACKGROUND
  • Stecco A, Gesi M, Stecco C, Stern R. Fascial components of the myofascial pain syndrome. Curr Pain Headache Rep. 2013 Aug;17(8):352. doi: 10.1007/s11916-013-0352-9.

    PMID: 23801005BACKGROUND
  • Jacobson JA. Shoulder US: anatomy, technique, and scanning pitfalls. Radiology. 2011 Jul;260(1):6-16. doi: 10.1148/radiol.11101082.

    PMID: 21697306BACKGROUND
  • Adstrum S, Hedley G, Schleip R, Stecco C, Yucesoy CA. Defining the fascial system. J Bodyw Mov Ther. 2017 Jan;21(1):173-177. doi: 10.1016/j.jbmt.2016.11.003. Epub 2016 Nov 16.

    PMID: 28167173BACKGROUND
  • RALSTON HJ 3rd, MILLER MR, KASAHARA M. Nerve endings in human fasciae, tendons, ligaments, periosteum, and joint synovial membrane. Anat Rec. 1960 Feb;136:137-47. doi: 10.1002/ar.1091360208. No abstract available.

    PMID: 14435991BACKGROUND
  • Benjamin M. The fascia of the limbs and back--a review. J Anat. 2009 Jan;214(1):1-18. doi: 10.1111/j.1469-7580.2008.01011.x.

    PMID: 19166469BACKGROUND
  • Dawidowicz J, Szotek S, Matysiak N, Mielanczyk L, Maksymowicz K. Electron microscopy of human fascia lata: focus on telocytes. J Cell Mol Med. 2015 Oct;19(10):2500-6. doi: 10.1111/jcmm.12665. Epub 2015 Aug 27.

    PMID: 26311620BACKGROUND
  • Gillies AR, Lieber RL. Structure and function of the skeletal muscle extracellular matrix. Muscle Nerve. 2011 Sep;44(3):318-31. doi: 10.1002/mus.22094.

    PMID: 21949456BACKGROUND
  • Ingber DE, Wang N, Stamenovic D. Tensegrity, cellular biophysics, and the mechanics of living systems. Rep Prog Phys. 2014 Apr;77(4):046603. doi: 10.1088/0034-4885/77/4/046603.

    PMID: 24695087BACKGROUND
  • Ingber DE. Tensegrity I. Cell structure and hierarchical systems biology. J Cell Sci. 2003 Apr 1;116(Pt 7):1157-73. doi: 10.1242/jcs.00359.

    PMID: 12615960BACKGROUND
  • Najrana T, Sanchez-Esteban J. Mechanotransduction as an Adaptation to Gravity. Front Pediatr. 2016 Dec 26;4:140. doi: 10.3389/fped.2016.00140. eCollection 2016.

    PMID: 28083527BACKGROUND
  • Giamberardino MA, Affaitati G, Fabrizio A, Costantini R. Myofascial pain syndromes and their evaluation. Best Pract Res Clin Rheumatol. 2011 Apr;25(2):185-98. doi: 10.1016/j.berh.2011.01.002.

    PMID: 22094195BACKGROUND
  • Yung E, Asavasopon S, Godges JJ. Screening for head, neck, and shoulder pathology in patients with upper extremity signs and symptoms. J Hand Ther. 2010 Apr-Jun;23(2):173-85; quiz 186. doi: 10.1016/j.jht.2009.11.004. Epub 2010 Feb 11.

    PMID: 20149960BACKGROUND
  • Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996 Jun;29(6):602-8. doi: 10.1002/(SICI)1097-0274(199606)29:63.0.CO;2-L.

    PMID: 8773720BACKGROUND
  • Beaton DE, Katz JN, Fossel AH, Wright JG, Tarasuk V, Bombardier C. Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. J Hand Ther. 2001 Apr-Jun;14(2):128-46.

    PMID: 11382253BACKGROUND
  • Constant CR, Murley AH. A clinical method of functional assessment of the shoulder. Clin Orthop Relat Res. 1987 Jan;(214):160-4.

    PMID: 3791738BACKGROUND

Related Links

MeSH Terms

Conditions

Shoulder Pain

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Bartosz Molik, Professor

    Józef Piłsudski University of Physical Education

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Student

Study Record Dates

First Submitted

April 15, 2018

First Posted

May 11, 2018

Study Start

May 25, 2018

Primary Completion

August 30, 2019

Study Completion

December 31, 2020

Last Updated

May 11, 2018

Record last verified: 2018-04